R&D Changing Faces: Pharma and biotech hires, September 2026 There was plenty of movement at the top of pharma and biotech in September, with leadership changes spanning some of the industry’s biggest names.
R&D Changing Faces: Pharma and biotech hires, August 2026 August brought another wave of leadership changes across biotech, pharma, and research organisations.
News AI, genomics expert leaves Pathos AI, will advise Pfizer Pfizer is creating the role of AI Scholar for computational biologist Eric Schadt, who is leaving Pathos AI to start a new stealth venture.
R&D Changing Faces: Pharma and biotech hires, June & July 2026 In June/July, companies continued to reshape their leadership teams in preparation for upcoming clinical, regulatory, and commercial milestones.
R&D Changing Faces: Pharma and biotech hires, May 2026 Looking back to May, the pharma and biotech sector saw a steady stream of senior leadership changes.
R&D Changing Faces: Pharma and biotech, April 2026 April didn’t see too much activity at the big pharmas, but saw plenty of executive movement at small and midsized biotechs.
Oncology On looking to a future multiomics approach for CDx, with Jan... The pharmaphorum podcast caught up with Jane Li, VP and general manager for companion diagnostics at Thermo Fisher Scientific, following ESMO 2026.
Sales & Marketing Sponsored Securing your ROI: Turning post-acquisition integration into... Join Forinnovia and Little Cube Consulting for a webinar on securing post-acquisition ROI.